Univec UNVC · USD

Its shares trade under the ticker UNVC. It has been listed since 24 April 1997. In the fiscal year to 31 December 2025, it reported revenue of $85,014 and a net loss of $1.2m. At that date it held total assets of $31,811 and shareholders' equity of −$17.7m.

Univec, Inc. engages in the provision of specialty pharmaceuticals. The company is headquartered in Baltimore, Maryland. The Company’s syringe division develops, licenses and markets auto-disable and safety syringes worldwide. The physician and pharmaceutical services division assists pharmaceutical companies in marketing, fulfillment and tracking drug samples via an online system connecting pharmacies and managed payment providers. The firm also manufactures and markets sliding sheath syringes designed to protect patients and healthcare workers from needle stick injuries, in compliance with the federal needlestick safety and prevention act of the United States government.

Figures and description from our data supplier, not checked against the company's own report.

• S. Robert GrassChairman of the Board, since 2002
• Mr. Lamont EllisPresident
• Dr. David DaltonChief Executive Officer, Director, since 2002$133,073
• Michael LesiskoChief Financial Officer, Treasurer, Secretary$12,500
• Raphael LangfordChief Operating Officer, Executive Vice President$13,333
• Mr. Lauren HerronVice President
• Mr. Michael KnightDirector
• William WooldridgeDirector

Overall

0

Environment

0

Social

0

Governance

0

Data on this tab

Our data supplier

Chart on the Overview

TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.